.png){kind=icon}
.png){kind=icon}
Return
Invasive candidiasis
.png){kind=icon}
PRE
AI
DOI：10.1038/s41572-024-00503-3.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Invasive candidiasis is an important fungal disease caused by Candida albicans and, increasingly, non-albicans Candida pathogens. Invasive Candida infections originate most frequently from endogenous human reservoirs and are triggered by impaired host defences. Signs and symptoms of invasive candidiasis are non-specific; candidaemia is the most diagnosed manifestation, with disseminated candidiasis affecting single or multiple organs. Diagnosis poses many challenges, and conventional culture techniques are frequently supplemented by non-culture-based assays. The attributable mortality from candidaemia and disseminated infections is similar to 30%. Fluconazole resistance is a concern for Nakaseomyces glabratus, Candida parapsilosis, and Candida auris and less so in Candida tropicalis infection; acquired echinocandin resistance remains uncommon. The epidemiology of invasive candidiasis varies in different geographical areas and within various patient populations. Risk factors include intensive care unit stay, central venous catheter use, broad-spectrum antibiotics use, abdominal surgery and immune suppression. Early antifungal treatment and central venous catheter removal form the cornerstones to decrease mortality. The landscape of novel therapeutics is growing; however, the application of new drugs requires careful selection of eligible patients as the spectrum of activity is limited to a few fungal species. Unanswered questions and knowledge gaps define future research priorities and a personalized approach to diagnosis and treatment of invasive candidiasis is of paramount importance.
Keywords:
ESCMID-ASTERISK GUIDELINE
CRITICALLY-ILL PATIENTS
CULTURE-CONFIRMED CANDIDEMIA
INTENSIVE-CARE UNITS
FLUCONAZOLE RESISTANCE
ANTIFUNGAL TREATMENT
SOUTH-AFRICA
ICU PATIENTS
RISK-FACTORS
AURIS
Journal
N
IF:
60.6
Papers:
647
Citations:
3.8W
Organization
View more organizations